ENHANCE: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)
Clinical trial NCT03602560 · COMPLETED
Trial details
- NCT number
- NCT03602560
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-01
- Primary completion
- 2020-02-16
- Enrollment
- 265
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.